Statement Of Income And Retained Earnings

Oncolys BioPharma Inc. - Filing #7611807

Concept 2021-01-01 to
2021-12-31
2021-01-01 to
2021-12-31
2021-01-01 to
2021-12-31
2021-01-01 to
2021-12-31
2020-01-01 to
2020-12-31
2020-01-01 to
2020-12-31
2020-01-01 to
2020-12-31
2020-01-01 to
2020-12-31
Statement of income and retained earnings
Statement of income and retained earnings
Operating profit (loss)
-1,454,554,000 JPY
-1,674,652,000 JPY
Non-operating income
Non-operating income
38,643,000 JPY
568,000 JPY
Non-operating expenses
Non-operating expenses
84,977,000 JPY
49,453,000 JPY
Ordinary profit (loss)
-1,500,888,000 JPY
-1,723,537,000 JPY
Extraordinary losses
Extraordinary losses
110,825,000 JPY
367,821,000 JPY
Profit (loss) before income taxes
-1,611,714,000 JPY
-2,091,359,000 JPY
Income taxes - current
3,725,000 JPY
3,727,000 JPY
Profit (loss)
-1,615,439,000 JPY
-1,615,439,000 JPY
-1,615,439,000 JPY
-1,615,439,000 JPY
-2,095,087,000 JPY
-2,095,087,000 JPY
-2,095,087,000 JPY
-2,095,087,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.